- Filed
- Apr 22, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 1.07B sh |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $19.25B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $19.34B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $34.94B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $34.39B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $104.65B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $103.58B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $37.58B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $37.64B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $124.12B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $123.14B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.1B sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $322M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $994M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $1.40 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.41 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.03B |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $270M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $1.54B |